Cargando…
12-month prevalence of known chronic obstructive pulmonary disease (COPD) in Germany
Chronic obstructive pulmonary disease (COPD) is associated with a high disease burden and is one of the leading causes of death worldwide. Smoking is the key modifiable risk factor for COPD in Germany. GEDA 2014/2015-EHIS surveyed the 12-month prevalence of known COPD using the European indicator on...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Robert Koch Institute
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165902/ https://www.ncbi.nlm.nih.gov/pubmed/37168950 http://dx.doi.org/10.17886/RKI-GBE-2017-065 |
Sumario: | Chronic obstructive pulmonary disease (COPD) is associated with a high disease burden and is one of the leading causes of death worldwide. Smoking is the key modifiable risk factor for COPD in Germany. GEDA 2014/2015-EHIS surveyed the 12-month prevalence of known COPD using the European indicator on self-reported chronic bronchitis, chronic obstructive pulmonary disease, emphysema. Among adults aged 18 years or older with complete information on the indicator (n=22,702), the 12-month prevalence of known COPD is 5.8% (5.8% for women and 5.7% for men). In both genders, the prevalence increases strongly with age. Overall, the presence of COPD was more often reported by women and men with a low educational level than by those with a higher one. In a comparison of federal states, the 12-month prevalence of known COPD varies between 3.6% and 7.5% for women and 4.3% and 11.2% for men. |
---|